V. Spiridonenko

Phytotherapy of chronic prostatitis in patients with metabolic syndrome and diabetes

The aim of this work - evaluation of the effectiveness of monotherapy Gentos Forte® in men with chronic prostatitis (CP) with diabetes mellitus (DM) and metabolic syndrome (MS). In group I (n = 42) included patients with CP who received only Gentos Forte® 1 capsule 3 times a day for three months, the second - 9 cases of CP receiving monotherapy tocopherol 400 mg per day. The control group consisted of healthy volunteers who had not received treatment (n = 8). Diagnostic tests were performed according to the standards of WHO and Ministry of Health of Ukraine. Within three months of the study it was found that in group I there was a decrease in symptoms of lower urinary tract scale IPSS on average 23,7±0,8%, and the average QoL score of 1 when compared to Group II, where the positive dynamics was unreliable. Improved erectile function IIEF indicating optimize performance of sexual activity in individuals in group I, when compared with those of Group II. In both groups there was an increase in prostate trophic activity as larger amounts of lecithin granules, while in group I was significant.

Monotherapy Gentos Forte® is a safe and effective method to quickly remove the lower urinary tract symptoms , stimulates trophic prostate function and improves erectile function in patients with diabetes and metabolic syndrome.